134 related articles for article (PubMed ID: 31354356)
21. Endocan as a prognostic biomarker of triple-negative breast cancer.
Sagara A; Igarashi K; Otsuka M; Kodama A; Yamashita M; Sugiura R; Karasawa T; Arakawa K; Narita M; Kuzumaki N; Narita M; Kato Y
Breast Cancer Res Treat; 2017 Jan; 161(2):269-278. PubMed ID: 27888420
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of Kinase Family 15 Inhibits Cancer Cell Proliferation In vitro and its Clinical Relevance in Triple-Negative Breast Cancer.
Sheng J; Xue X; Jiang K
Curr Mol Med; 2019; 19(2):147-155. PubMed ID: 30854965
[TBL] [Abstract][Full Text] [Related]
23. Proliferation, migration and invasion of triple negative breast cancer cells are suppressed by berbamine via the PI3K/Akt/MDM2/p53 and PI3K/Akt/mTOR signaling pathways.
Liu L; Yan J; Cao Y; Yan Y; Shen X; Yu B; Tao L; Wang S
Oncol Lett; 2021 Jan; 21(1):70. PubMed ID: 33365081
[TBL] [Abstract][Full Text] [Related]
24. A Novel IGLC2 Gene Linked With Prognosis of Triple-Negative Breast Cancer.
Chang YT; Tsai WC; Lin WZ; Wu CC; Yu JC; Tseng VS; Liao GS; Hu JM; Hsu HM; Chang YJ; Lin MC; Chu CM; Yang CY
Front Oncol; 2021; 11():759952. PubMed ID: 35155184
[TBL] [Abstract][Full Text] [Related]
25. Methionine adenosyltransferases in cancers: Mechanisms of dysregulation and implications for therapy.
Maldonado LY; Arsene D; Mato JM; Lu SC
Exp Biol Med (Maywood); 2018 Jan; 243(2):107-117. PubMed ID: 29141455
[TBL] [Abstract][Full Text] [Related]
26. MELK as a potential target to control cell proliferation in triple-negative breast cancer MDA-MB-231 cells.
Li G; Yang M; Zuo L; Wang MX
Oncol Lett; 2018 Jun; 15(6):9934-9940. PubMed ID: 29805690
[TBL] [Abstract][Full Text] [Related]
27. UNBS5162 induces growth inhibition and apoptosis via inhibiting PI3K/AKT/mTOR pathway in triple negative breast cancer MDA-MB-231 cells.
Yue X; Li M; Chen D; Xu Z; Sun S
Exp Ther Med; 2018 Nov; 16(5):3921-3928. PubMed ID: 30344670
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
[TBL] [Abstract][Full Text] [Related]
29. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
[TBL] [Abstract][Full Text] [Related]
30. FOXO3a expression is associated with lymph node metastasis and poor disease-free survival in triple-negative breast cancer.
Rehman A; Kim Y; Kim H; Sim J; Ahn H; Chung MS; Shin SJ; Jang K
J Clin Pathol; 2018 Sep; 71(9):806-813. PubMed ID: 29588373
[TBL] [Abstract][Full Text] [Related]
31. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
32. Gomisin G Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing AKT Phosphorylation and Decreasing Cyclin D1.
Maharjan S; Park BK; Lee SI; Lim Y; Lee K; Kwon HJ
Biomol Ther (Seoul); 2018 May; 26(3):322-327. PubMed ID: 29587339
[TBL] [Abstract][Full Text] [Related]
33. Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells.
Cook MT; Liang Y; Besch-Williford C; Hyder SM
Breast Cancer (Dove Med Press); 2017; 9():9-19. PubMed ID: 28096694
[TBL] [Abstract][Full Text] [Related]
34. CPNE1 predicts poor prognosis and promotes tumorigenesis and radioresistance via the AKT singling pathway in triple-negative breast cancer.
Shao Z; Ma X; Zhang Y; Sun Y; Lv W; He K; Xia R; Wang P; Gao X
Mol Carcinog; 2020 May; 59(5):533-544. PubMed ID: 32181526
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of cell division cycle-associated protein 4 expression inhibits proliferation of triple negative breast cancer MDA-MB-231 cells
Pang S; Xu Y; Chen J; Li G; Huang J; Wu X
Oncol Lett; 2019 May; 17(5):4393-4400. PubMed ID: 30944632
[TBL] [Abstract][Full Text] [Related]
36. Varlitinib Downregulates HER/ERK Signaling and Induces Apoptosis in Triple Negative Breast Cancer Cells.
Liu CY; Chu PY; Huang CT; Chen JL; Yang HP; Wang WL; Lau KY; Lee CH; Lan TY; Huang TT; Lin PH; Dai MS; Tseng LM
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30658422
[TBL] [Abstract][Full Text] [Related]
37. hMAGEA2 promotes progression of breast cancer by regulating Akt and Erk1/2 pathways.
Park S; Sung Y; Jeong J; Choi M; Lee J; Kwon W; Jang S; Park SJ; Kim HS; Lee MH; Kim DJ; Liu K; Kim SH; Dong Z; Ryoo ZY; Kim MO
Oncotarget; 2017 Jun; 8(23):37115-37127. PubMed ID: 28415749
[TBL] [Abstract][Full Text] [Related]
38. Targeting PVT1 Exon 9 Re-Expresses Claudin 4 Protein and Inhibits Migration by Claudin-Low Triple Negative Breast Cancer Cells.
Levine F; Ogunwobi OO
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33801373
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of nucleophosmin 1 suppresses proliferation of triple-negative breast cancer cells through activating CDH1/Skp2/p27kip1 pathway.
Zeng D; Xiao Y; Zhu J; Peng C; Liang W; Lin H
Cancer Manag Res; 2019; 11():143-156. PubMed ID: 30613163
[TBL] [Abstract][Full Text] [Related]
40. MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147.
Wang C; Xu C; Niu R; Hu G; Gu Z; Zhuang Z
BMC Cancer; 2019 Jun; 19(1):577. PubMed ID: 31196010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]